Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Besse

Showing results (11-20 of 511) with videos related to

Pageof 52
Sort By:
Bulletin Du Cancer|September 13, 2007
[Gemcitabine and non small-cell lung cancer]Stéphane Vignot, Benjamin Besse
Bulletin Du Cancer|November 6, 2007
[Angiogenesis targeting in lung cancers]David Planchard, Benjamin Besse
Nature|June 17, 2018
New windows open for immunotherapy in lung cancerLizza Hendriks, Benjamin Besse
Bulletin Du Cancer|November 14, 2008
[Towards customized therapy for non small cell lung cancer]David Planchard, Benjamin Besse
Translational Lung Cancer Research|July 23, 2021
Immunotherapy in other thoracic malignancies and uncommon populationsJordi Remon, Benjamin Besse
Nature Reviews. Clinical Oncology|October 28, 2021
Adjuvant immunotherapy for NSCLC - does treating earlier mean treating better?Jordi Remon, Benjamin Besse
La Revue Du Praticien|February 11, 2022
[Immunotherapy for non-small-cell lung cancer]Maxime Frelaut, Benjamin Besse
Oncology (Williston Park, N.Y.)|June 24, 2009
Adjuvant or induction cisplatin-based chemotherapy for operable lung cancerBenjamin Besse, Thierry Le Chevalier
Bulletin Du Cancer|November 27, 2002
[Gemcitabine and breast cancer]Benjamin Besse, Jean-Philippe Spano
La Revue Du Praticien|March 14, 2012
[Personalized medicine in oncology: from hope to reality]Benjamin Besse, Jean-charles Soria
Pageof 52

Showing results (11-20 of 511) with videos related to

Sort By:
Pageof 52
Bulletin Du Cancer|September 13, 2007
[Gemcitabine and non small-cell lung cancer]Stéphane Vignot, Benjamin Besse
Bulletin Du Cancer|November 6, 2007
[Angiogenesis targeting in lung cancers]David Planchard, Benjamin Besse
Nature|June 17, 2018
New windows open for immunotherapy in lung cancerLizza Hendriks, Benjamin Besse
Bulletin Du Cancer|November 14, 2008
[Towards customized therapy for non small cell lung cancer]David Planchard, Benjamin Besse
Translational Lung Cancer Research|July 23, 2021
Immunotherapy in other thoracic malignancies and uncommon populationsJordi Remon, Benjamin Besse
Nature Reviews. Clinical Oncology|October 28, 2021
Adjuvant immunotherapy for NSCLC - does treating earlier mean treating better?Jordi Remon, Benjamin Besse
La Revue Du Praticien|February 11, 2022
[Immunotherapy for non-small-cell lung cancer]Maxime Frelaut, Benjamin Besse
Oncology (Williston Park, N.Y.)|June 24, 2009
Adjuvant or induction cisplatin-based chemotherapy for operable lung cancerBenjamin Besse, Thierry Le Chevalier
Bulletin Du Cancer|November 27, 2002
[Gemcitabine and breast cancer]Benjamin Besse, Jean-Philippe Spano
La Revue Du Praticien|March 14, 2012
[Personalized medicine in oncology: from hope to reality]Benjamin Besse, Jean-charles Soria
Pageof 52